Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

Author： Pliarchopoulou K.   Kalogeras K.   Kronenwett R.   Wirtz R.   Eleftheraki A.   Batistatou A.   Bobos M.   Soupos N.   Polychronidou G.   Gogas H.   Samantas E.   Christodoulou C.   Makatsoris T.   Pavlidis N.   Pectasides D.   Fountzilas G.  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.71, Iss.1, 2013-01, pp. : 245-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

By Papadimitriou Christos   Papakostas Pavlos   Timotheadou Eleni   Aravantinos Gerasimos   Bamias Aristotelis   Fountzilas George  

Cancer Investigation, Vol. 26, Iss. 5, 2008-06 ,pp. : 491-498

Informa Healthcare

Access to resources Recommend Favorite

Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: A Hellenic Cooperative Oncology Group (HeCOG) study

By                                  

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 216-224

Spandidos Publications

Access to resources Recommend Favorite

mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy

By Wang C.S.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 1, 1997-08 ,pp. : 63-74

Springer Publishing Company

Access to resources Recommend Favorite

Tamoxifen in High-risk Premenopausal Women with Primary Breast Cancer Receiving Adjuvant Chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B Trial

By Andersson M.   Kamby C.   Jensen M.-B.   Mouridsen H.   Ejlertsen B.   Dombernowsky P.   Rose C.   Cold S.   Overgaard M.   Andersen J.   Kjaer M.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1659-1666

Elsevier

Access to resources Recommend Favorite

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study

By Mansi Janine   Yellowlees Ann   Lipscombe Julian   Earl Helena   Cameron David   Coleman Robert   Perren Timothy   Gallagher Christopher   Quigley Mary   Crown John   Jones Alison   Highley Martin   Leonard Robert   Jeffry Evans T.  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 787-794

Springer Publishing Company

Access to resources Recommend Favorite